83269-12-9 Usage
Uses
Used in Pharmaceutical Research:
PNU-102035 is used as a pharmacological tool for studying the adenosine A1 receptor and its role in physiological processes. This application aids in understanding the receptor's function and its potential as a therapeutic target for various conditions.
Used in Neurodegenerative Disease Treatment:
In the medical field, (5-Amino-1,2-dihydro-1-methyl-3-phenylpyrido[3,4-b]pyrazin-7-yl)carbamic acid ethyl ester is used as a potential therapeutic agent for the treatment of neurodegenerative diseases. Its neuroprotective properties make it a candidate for conditions such as Alzheimer's, Parkinson's, and other related disorders.
Used in Chronic Pain Management:
PNU-102035 is being investigated for its potential use in managing chronic pain. As an adenosine A1 receptor antagonist, it may help in modulating pain signals and providing relief to patients suffering from chronic pain conditions.
Used in Cognitive and Psychiatric Illness Treatment:
(5-Amino-1,2-dihydro-1-methyl-3-phenylpyrido[3,4-b]pyrazin-7-yl)carbamic acid ethyl ester is also being studied for its potential role in treating cognitive disorders and psychiatric illnesses. Its ability to modulate neurotransmitter release could contribute to the development of new treatment strategies for these conditions.
Used in Drug Delivery Systems:
Similar to gallotannin, PNU-102035 may benefit from novel drug delivery systems to enhance its applications and efficacy. These systems could improve the compound's delivery, bioavailability, and therapeutic outcomes in various medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 83269-12-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,2,6 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 83269-12:
(7*8)+(6*3)+(5*2)+(4*6)+(3*9)+(2*1)+(1*2)=139
139 % 10 = 9
So 83269-12-9 is a valid CAS Registry Number.
InChI:InChI=1/C17H19N5O2/c1-3-24-17(23)21-14-9-13-15(16(18)20-14)19-12(10-22(13)2)11-7-5-4-6-8-11/h4-9H,3,10H2,1-2H3,(H3,18,20,21,23)
83269-12-9Relevant academic research and scientific papers
1,2-Dihydropyrido[3,4-b]pyrazines: Structure-activity relationships
Temple Jr.,Wheeler,Elliott,Rose,Comber,Montgomery
, p. 91 - 95 (2007/10/02)
Certain derivatives containing the 1,2-dihydropyrido[3,4-b]pyrazine (1-deaza-7,8-dihydropteridine) ring system are active against experimental neoplasms in mice. The mechanism of action of these agents has r539w1 =4-amino-1-deaza-7,8-dihydro-6-[(N-methyla
